IRADIMED CORPORATION Sustainability Profile
IRADIMED CORPORATION, headquartered in the United States, is a pioneering force in the medical device industry, specialising in innovative solutions for MRI-compatible anaesthesia delivery. Founded in 2006, the company has made significant strides in enhancing patient safety and comfort during MRI procedures. With a focus on developing unique, non-magnetic anaesthesia systems, IRADIMED has established itself as a leader in the field, offering products that are specifically designed to operate seamlessly within MRI environments. Their flagship product, the MRI-compatible anaesthesia machine, stands out for its advanced technology and user-friendly design, ensuring optimal performance without compromising patient care. Recognised for its commitment to quality and innovation, IRADIMED CORPORATION continues to expand its market presence, serving healthcare facilities across the globe and contributing to improved outcomes in anaesthesia management.
DitchCarbon Score
How does IRADIMED CORPORATION's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
IRADIMED CORPORATION's score of 25 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
IRADIMED CORPORATION's reported carbon emissions
IRADIMED CORPORATION, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Consequently, there are no documented Scope 1, 2, or 3 emissions to analyse. Furthermore, the company has not established any reduction targets or commitments under the Science Based Targets initiative (SBTi) or other climate pledges. This lack of data suggests that IRADIMED CORPORATION may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the industry increasingly prioritises sustainability, IRADIMED CORPORATION's future climate commitments and emissions reporting will be crucial for aligning with best practices and meeting stakeholder expectations.
How Carbon Intensive is IRADIMED CORPORATION's Industry?
How Carbon Intensive is IRADIMED CORPORATION's Location?
IRADIMED CORPORATION's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
IRADIMED CORPORATION has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
